Per the FDA, if you administer any of the following drugs, you must inspect the powder and reconstituted liquid for particles and use a filter. There is possible contamination with stainless steel particles, non-latex rubber, and fiber-like material. Since there are no comparable drugs, they are not recalling them.
ï¿½Imiglucerase (Cerezyme), a Gaucher disease intravenous drug
ï¿½Agalsidase beta (Fabrazyme), a Fabry disease intravenous infusion
ï¿½Alglucosidase alpha (Myozyme), a Pompe disease intravenous infusion
ï¿½Laronidase (Aldurazyme liquid solution), a Mucopolysaccharidosis type I-IV infusion
ï¿½Thyrotropin alpha (Thyrogen), an adjunctive diagnostic tool and treatment for thyroid cancer via intramuscular injection